New developments in hereditary hemochromatosis

American Journal of the Medical Sciences

Volumn 318, Issue 4, 1999, Pages 257-268

  Felitti, Vincent J ^a   Beutler, Ernest ^b  

^a KAISER PERMANENTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Hemochromatosis; HFE; Iron; Mutation; Storage

Indexed keywords

ASCORBIC ACID; BETA 2 MICROGLOBULIN; CALNEXIN; CALRETICULIN; CHELATING AGENT; DEFEROXAMINE; FERRITIN; IRON;

CONFERENCE PAPER; EARLY DIAGNOSIS; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON OVERLOAD; IRON STORAGE; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHLEBOTOMY; PROGNOSIS; SCREENING TEST;

EID: 0033511076     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40629-9     Document Type: Conference Paper

References (55)

1. Sheldon JH. Haemochromatosis. London: Oxford University Press; 1935. p. 1.
2. MacDonald RA. Idiopathic hemochromatosis. Genetic or acquired? Arch Intern Med 1963;112:82-8.
3. MacDonald RA. Primary hemochromatosis: Inherited or acquired? Prog Hematol 1966;5:324-53.
4. Simon M, Bourel R, Fauchet R, et al. Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 1976;17:332-4.
5. Mallory FB. Hemochromatosis and chronic poisoning with copper. Arch Intern Med 1926;37:336-62.
6. Davis WD, Arrowsmith WR. The effect of repeated phlebotomies in hemochromatosis. J Lab Clin Med 1952;39:526-32.
7. Butt EM, Nusbaum RE, Gilmour TC, et al. Trace metal patterns in disease states. I. Hemochromatosis and refractory anemia. Am J Clin Pathol 1956;26:225-42.
8. Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood 1989;74:2187-93.
9. Britton RS, Tavill AS, Bacon BR. Mechanism of iron toxicity. In: Brock JH, Halliday JQ, Pippard MJ, et al, editors. Iron metabolism in health and disease. Philadelphia: W B Saunders; 1994. p. 311-51.
10. Crosby WH. Unsolved problems in hemochromatosis. Ann NY Acad Sci 1988;526:323-7.
11. Bonkovsky HL, Ponka P, Bacon BR, et al. An update on iron metabolism: Summary of the Fifth International Conference on disorders of iron metabolism. Hepatology 1996;24: 718-29.
12. Barton JC, Edwards CQ, Bertoli LF, et al. Iron overload in African Americans. Am J Med 1995;99:616-23.
13. Cutler P. Deferoxamine in the arthropathy of hemochromatosis. J Neurol Orthop Med Surg 1993;14:90-2.
14. Deleted in proof.
15. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
16. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95:1472-7.
17. Lebrón JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93: 111-23.
18. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272:14025-8.
19. de Sousa M, Reimao R, Lacerda R, et al. Iron overload in beta 2-microglobulin-deficient mice. Immunol Lett 1994;39: 105-11.
20. 2 Knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A 1996;93:1529-34.
21. Beutler E, West C, Gelbart T, et al. Commentary on: Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:145a-b.
22. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997;61:762-4.
23. Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997;349:296-7.
24. Risch N. Haemochromatosis, HFE, and genetic complexity. Nat Genet 1997;17:375-6.
25. Barton JC, Shih WWH, Sawada-Hirai R, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:135-45.
26. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-51.
27. Beutler E, West C, Gelbart T. HLA-H and associated proteins in patients with hemochromatosis. Mol Med 1997;3: 397-402.
28. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
29. Conrad ME, Umbreit JN, Moore EG. Rat duodenal ironbinding protein mobilferrin is a homologue of calreticulin. Gastroenterology 1993;104:1700-4.
30. Conrad ME, Umbreit JN. Iron absorption-the mucin-mobilferrin-integrin pathway. A competitive pathway for metal absorption. Am J Hematol 1993;42:67-73.
31. Conrad ME, Umbreit JN, Moore EG, et al. A newly identified iron binding protein in duodenal mucosa of rats. J Biol Chem 1990;265:5273-9.
32. Fleming MD, Trenor CC 3rd, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-6.
33. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-8.
34. Fleming MD, Romano MA, Su MA, et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 1998;95:1148-53.
35. Edwards CQ, Griffen LM, Kushner JP. Comparison of stainable liver iron between symptomatic and asymptomatic hemochromatosis homozygotes and their homozygous relatives. Am J Med Sci 1991;301:44-6.
36. Weinberg ED. Iron withholding: a defense against viral infections. Biometals 1996;9:393-9.
37. Sargent T 3rd, Lim TH, Jenson RL. Reduced chromium retention in patients with hemochromatosis, a possible basis of hemochromatotic diabetes. Metabolism 1979;28:70-9.
38. Griffiths E. Iron in biological systems. In: Bullen JJ, Griffiths E, editors. Iron and infection. Chichester (UK): John Wiley & Sons; 1987. p. 2-25.
39. Weinberg ED. Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984;64:65-102.
40. Barton JC, Bertoli LF, Janich MR, et al. Normal transferrin saturation in hemochromatosis. Hosp Pract (Off Ed) 1991;26(Suppl 3):46-8.
41. Moirand R, Mortaji AM, Loreal O, et al. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-7.
42. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9.
43. Witte DL, Crosby WH, Edwards CQ, et al. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
44. Beutler E, Demina A, Laubscher K, et al. The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells Mol Dis 1995;21:86-108.
45. Chapman RWG, Williams G, Bydder G, et al. Computed tomography for determining liver iron content in primary haemochromatosis. Br Med J 1980;1:440-2.
46. Jersen PD, Jersen FT, Christensen T, et al. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994;87:171-84.
47. Ernst O, Sergent G, Bonvarlet P, et al. Hepatic iron overload:diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-8.
48. Brittenham GM, Farrell DE, Harris JW et al. Magnetic susceptibility measurement of human iron stores. N Engl J Med 1982;307:1671-5.
49. Haskins D, Stevens AR Jr, Finch SC, Finch CA. Iron metabolism. Iron stores in man as measured by phlebotomy. J Clin Invest 1952;31:543-7.
50. Camaschella C, Roetto A, Cicilano M, et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997;5:371-5.
51. Kowdley KV, Trainer TD, Saltzman JB, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 1997;113:1270-7.
52. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997;113:995-9.
53. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1266-62.
54. Düllmann J, Wulfhekel U. The diagnostic significance of bone-marrow iron in hereditary hemochromatosis. Ann N Y Acad Sci 1998;526:357-60.
55. Crawford R. The iron elephant. Glyndon (MD): Vida Press; 1992.